New Daily Diabetes Pill for Weight Loss Launches in UK Pharmacies

Foundayo, a daily oral medication that treats type 2 diabetes and promotes weight loss, will be available in UK pharmacies on private prescriptions from Monday. The drug, which belongs to the GLP‑1 receptor‑agonist class, offers an alternative for patients who cannot or prefer not to use injectable weight‑loss treatments.

Pharmacists welcomed the new option, noting it expands access for individuals who have difficulty with or refuse injections. However, they also issued a cautionary note about a rising issue of counterfeit, unlicensed or fake GLP‑1 tablets circulating in the market, urging consumers to obtain the medication only from reputable pharmacies and to verify the authenticity of the product.

The introduction of Foundayo is expected to broaden therapeutic choices for people managing diabetes and weight, while the pharmacist warning underscores the need for vigilance against counterfeit drugs that could compromise patient safety.